Genomics for Drug Research and Development Cora Vacher Market Development Manager – Complex Diseases OCT 11, 2016
© 2016 Illumina, Inc. All rights reserved. Illumina, 24sure, BaseSpace, BeadArray, BlueFish, BlueFuse, BlueGnome, cBot, CSPro, CytoChip, DesignStudio, Epicentre, ForenSeq, Genetic Energy, GenomeStudio, GoldenGate, HiScan, HiSeq, HiSeq X, Infinium, iScan, iSelect, MiniSeq, MiSeq, MiSeqDx, MiSeq FGx, NeoPrep, NextBio, Nextera, NextSeq, Powered by Illumina, SureMDA, TruGenome, TruSeq, TruSight, Understand Your Genome, UYG, VeraCode, verifi, VeriSeq, the pumpkin orange color, and the streaming bases design are trademarks of Illumina, Inc. and/or its affiliate(s) in the US and/or other countries. All other names, logos, and other trademarks are the property of their respective owners.
Illumina Mission To advance human health by unlocking the power of the genome From Genome Wide Discovery…
To Targeted Validation and Beyond…
2
Leading the Global Sequencing Presence
>90% 78,629 *Data calculations on file. Illumina, Inc., 2015 **Data calculations on file. Illumina, Inc., Q3 2016.
3
of the world’s sequencing data is generated using Illumina SBS technology*
publications to date reference or use Illumina (excluding reviews)**
Illumina Platforms SEQUENCING SYSTEMS | Sequencing by Synthesis (SBS) POPULATION POWER
PRODUCTION POWER
FLEXIBLE POWER
NextSeq® 500/550
HiSeq® 4000
HiSeq X® Ten
HiSeq 3000
FOCUSED POWER
MiSeq®
HiSeq X Five
HiSeq 2500
MiSeqDx® For in vitro diagnostic use
ARRAY SCANNING | Infinium® MiSeq FGx™ CUTTING-EDGE ARRAY SCANNER
iScan®
4
For Research Use Only. Not for use in diagnostic procedures.
MiniSeq™
Driving Discovery and Association Illumina genomic continuum
Explain and verify findings
Get statistical power for targeted variants
Custom arrays • Evaluate and validate variants • Deliver high-throughput screening
Explain and verify findings at largest scale
Next-generation sequencing • Identify novel variants • Provide targeted resequencing • Gene expression • Methylation
Get statistical power for novel variants
Arrays • Genotyping • Methylation
5
For Research Use Only. Not for use in diagnostic procedures.
Custom arrays • Enable focused genotyping studies
Integrated approach for Drug Development Pipeline Illumina solution for the future of drug discovery DNA Analysis Target Identification
Oncology
RNA Analysis Target Validation
NextSeq, MiSeq
Preclinical Development
Instruments
HiSeq, HiSeqX Ten, NextSeq, iScan
NextSeq, MiSeq
Informatics
BaseSpace®, BaseSpace Onsite, NextBio® Research
GWAS Studies Infinium, iSelect®
Companion DX
Clinical Development Phase I Phase II Phase III
Post Approval
MiSeq, MiSeqDx
MiSeqDx
BaseSpace, BaseSpace Onsite, MSR, VariantStudio, Cohort Analyser/Correlation Engine (CA/CE)
MSR, VariantStudio, Cohort Analyser/Correlation Engine (CA/CE)
Candidate Genotyping iSelect®
Biomarker discovery Resequencing, de novo sequencing Transcriptome profiling RNA-Sequencing Gene Regulation microRNA
SNV Screening Exome and Custom re-sequencing (biomarker validation) Toxigenomics RNASequencing
Gene Expression Profiling RNA-Sequencing Companion Diagnostics DNA, RNA Single Target analysis
Gene Regulation Chip Seq, WG Methyl analysis
Oncology: Candidate Analysis Target resequencing, custom GTP, (biomarkers validation)
6
For Research Use Only. Not for use in diagnostic procedures.
BioProcess Applications Overview of applications for biopharmaceutical QA/QC testing Cell line development and scale up
Bioreactor Production
Harvest, Recovery
Purification
Formulation
Release
RNA Analysis
DNA Analysis
Cell line characterization and monitoring, raw material testing Whole genome resequencing, Amplicon sequencing / HiSeq, MiSeq
Vector characterization Plasmid sequencing / HiSeq, MiSeq Sterility testing 16s Sequencing for microbial identification / MiSeq
Cell line characterization: gene expression RNA-Seq /HiSeq, MiSeq Virus detection – raw materials and cell lines RNA-Seq / HiSeq
7
For Research Use Only. Not for use in diagnostic procedures.
Illumina’s range of Professional Care Services Illumina Concierge Custom Design Service Personalized consulting solution for customers who need assistance in the design and delivery of custom content for genomics projects.
Illumina FastTrack™ services portfolio of array and next-generation sequencing (NGS) services to support a broad range of genomic applications.
Illumina Bioinformatics Professional Services Accelerate your research with personalized consultations and hands-on training from Illumina experts. 8
Pharma: Value Proposition Solutions along the drug development cycle
Illumina
Value Prop
Target Identification
10
Identify novel disease associations
GWAS/Arrays Exome Seq WGS, RNASeq
Drug Screening
Early Phase Trials
Alternative development for non-responders
GWAS/ Arrays Exome Seq WGS, Targeted Seq
Late Phase Trials
Reduce serious Adverse Drug Reactions
Market Surveillance
Favorable reimbursement / formulary position
Illumina IVD/CDx Partnerships & Development
Questions?
Cora Vacher, PhD Market Development Manager Complex Diseases
Carla Simoes Marketing Technical Specialist UK & Ireland
Eva Baker, Ph.D. Senior Territory Account Manager
Mobile: +44 7881 907192 Email:
[email protected]
Mobile: +44 7780 449412 E-mail:
[email protected]
Mobile:+ 44 7469 219455 E-mail:
[email protected]
11